Anti Virus Trial Links
ANA598 Demonstrates SVR12 in 100% of First Group of HCV Patients Randomized to Stop All Treatment at Week 24
Antigenics Reports Second Quarter 2010 Financial Results
Africa: Aids 2010 Calls for Resources, Ends With Strong Science Findings
Anadys Pharmaceuticals Reports Second Quarter 2010 Financial Results And Highlights
BD third-quarter revenues increase 3.2% to $1.878 billion